Suppliers of
Polymedco sponsors continuing medical educational events for healthcare professionals across the country. You can register for upcoming sessions here, or watch archived webinar recordings at any time, from anywhere.
These Polymedco-sponsored events are presented by key opinion leaders in the world of healthcare and research, and managed by Whitehat Communications to ensure a professional environment.
All programs are free, and offer P.A.C.E.® Continuing Education Credits for up to six months after the live event. Be sure to check back often for new event postings.
Unlocking Rapid Diagnosis: The Power of POC hsTnI, NT-proBNP, and D-Dimer in Emergency Departments
Wednesday, November 13, 2024 | 1:00 - 2:00 PM ET
PACE® Credit available until May 13, 2025 | Florida Lab Credit available
This webinar will present a multi-marker diagnostic strategy that integrates the use of Troponin, Natriuretic Peptides (BNP/NT-proBNP), and D-dimer to improve diagnostic accuracy in emergency medicine. The webinar will cover how to incorporate these biomarkers into standardized clinical pathways and decision-making algorithms, optimizing patient care and reducing unnecessary testing or imaging. By adopting this strategy, attendees will be able to reduce diagnostic uncertainty, which will lead to faster, more effective treatments, better patient outcomes, and improved workflow efficiency in both laboratory and emergency departments.
Natriuretic Peptides for the Diagnosis and Prognosis of Heart Failure
Wednesday, May 31, 2023 | 1:00 - 2:00 PM ET
PACE® Credit available until December 1, 2023 | Florida Lab Credit available
Interpretation of natriuretic peptides comes with caveats and part of the focus of this webinar will be to gain not just an understanding of the signs and symptoms of HF and the associated diagnostic thresholds for BNP and NT-proBNP, but learn about comorbidities such as renal disease and obesity and how these may impact the levels of natriuretic peptides in the presence or absence of heart failure. This webinar will also focus on understanding other cardiovascular diseases that may influence natriuretic peptide levels and the prognostic implications of an elevated level with and without a diagnosis of heart failure.
The Clinical Evolution of NT-proBNP: From Diagnosis and Prognosis to Guiding Therapy
Tuesday, May 21, 2024 | 1:00 - 2:00 PM ET
PACE® Credit available until November 21, 2024 | Florida Lab Credit available
Heart Failure (HF) afflicts a great many elderly Americans and is the compromised ability of the heart to pump sufficient blood to meet the patient’s physiological demands.
Interpretation of natriuretic peptides comes with caveats and part of the focus of this talk will be to gain not just an understanding of the signs and symptoms of HF and the associated diagnostic thresholds for BNP and NT-proBNP but learn about comorbidities such as renal disease and obesity and how these may impact the levels of natriuretic peptides in the presence or absence of heart failure. In addition, we will discuss whether NT-proBNP levels can be used to guide and optimize ambulatory patient treatment to reduce hospitalization and death.
Chest Pain Risk Stratification: Moving Beyond the HEART Score
Wednesday, March 29, 2023 | 1:00 - 2:00 PM ET
PACE® Credit available until September 29, 2023 | Florida Lab Credit available
Acute coronary syndrome (ACS) is a leading cause of morbidity and mortality worldwide. Each year, 7-9 million patients with symptoms of possible ACS present to U.S. emergency departments (EDs).
In response, most ED providers have adopted a highly conservative approach and over-test patients with possible ACS. This approach leads to lengthy hospital-based evaluations; prolonging ED stays, exacerbating ED and hospital crowding, and costing over $3 billion annually. In low-risk patients these evaluations are associated with increased iatrogenic risks from false positive testing, radiation exposure, and anxiety without improvement in clinical outcomes. Thus, current ED care patterns for patients with possible ACS are not sustainable from a healthcare quality or economic perspective.
Biomarker Based Community Screening for Cardiovascular Risk
Tuesday, September 26, 2023 | 1:00 - 2:00 PM ET
PACE® Credit available until March 26, 2024 | Florida Lab Credit available
This webinar will highlight novel approaches to community outreach and present innovative pathways to high throughput screening with an emphasis on use of multidimensional data to target specific neighborhoods. In doing so, this webinar will address problems related to underdiagnosis of cardiovascular disease which contribute to premature morbidity and mortality, and help clinicians/institutions conceptualize approaches to improve health outcomes in the communities they serve. By detecting disease early, downstream consequences such as heart attacks and strokes can be preventing, improving longevity and enhancing lifespan equality.
Management of Rural Patients with Cardiovascular Complaints
Wednesday, February 8, 2023 | 1:00 - 2:00 PM ET
PACE® Credit available until August 8, 2023 | Florida Lab Credit available
Rural Americans are more likely to be unhealthy, older, living in poverty, uninsured, and medically underserved compared to residents of urban communities. These differences lead to higher cardiovascular death rates and attenuation in the mortality reduction from medical breakthroughs in rural areas when compared to urban communities. Mortality differences are multifactorial, but include increased alcohol and drug use, smoking, and poor diet as well as joblessness and physical inactivity.
The American Heart Association (AHA) has clearly stated their commitment to reduce health disparities and recently issued a presidential advisory and “Call to Action” for stakeholders to prioritize rural communities in all capacities including research, education, and quality improvement. This webinar will assist you in providing evidence-based care to your rural patients presenting with dypnea and or chest pain..